Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04926324
Title A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Joseph Caster, Ph.D., M.D.

rectum cancer


Dostarlimab-gxly + Niraparib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.